Hepatitis C News
Week Ending September 13, 2021

Dr. Parikh on Future Research Directions in Hepatitis C-Related HCC
“Neehar Parikh, MD, medical director, Multidisciplinary Liver Tumor Clinic, medical director, Living Donor Liver Transplantation Program, assistant professor, University of Michigan Health, Michigan Medicine, discusses future research directions in hepatitis C-related hepatocellular carcinoma (HCC).”

HCV Patients with HIV Coinfection Have Triple the Risk for Non-Liver-Related Cancer
“Patients with hepatitis C virus (HCV) infections who had an HIV coinfection had a 3.7-fold higher risk of non-liver-related cancer than those without HIV coinfection, according to a new study in France.”

Pathogenesis of hepatitis C virus-related hepatocellular carcinoma: evidence from recent studies
“Hepatocellular carcinoma (HCC) represents primary liver cancer and is problematic worldwide because it is the major reason for cancer-related death. Various risk factors for developing HCC include advanced liver fibrosis, alcohol abuse, non-alcoholic steatohepatitis (NASH), primary biliary cholangitis, and autoimmune hepatitis. Particularly, infection of chronic hepatitis virus is an important risk factor for HCC, although viral activities could be efficiently controlled with the use of oral medications.”

Hepatitis C and joint pain: What is the link?
“The hepatitis C virus (HCV) often does not always cause symptoms, but if the infection becomes chronic, it can cause complications over time. One of these is joint inflammation and pain.”

Impact of Subscription-Based Payment Models on Hepatitis C Virus Prescription Fills Covered by Medicaid in Louisiana, Washington
“For individuals with hepatitis C virus (HCV) enrolled in Medicaid, the implementation of a subscription-based payment model (SBPM) was associated with a significant increase in prescription fills of Medicaid-covered HCV medications among those residing in Louisiana, but not among those in Washington, according to study results published in JAMA Health Forum.“